JP2014507482A5 - - Google Patents

Download PDF

Info

Publication number
JP2014507482A5
JP2014507482A5 JP2013557912A JP2013557912A JP2014507482A5 JP 2014507482 A5 JP2014507482 A5 JP 2014507482A5 JP 2013557912 A JP2013557912 A JP 2013557912A JP 2013557912 A JP2013557912 A JP 2013557912A JP 2014507482 A5 JP2014507482 A5 JP 2014507482A5
Authority
JP
Japan
Prior art keywords
subject
lung
safakutan
bets
msc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013557912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014507482A (ja
JP6204830B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/028524 external-priority patent/WO2012125471A1/en
Publication of JP2014507482A publication Critical patent/JP2014507482A/ja
Publication of JP2014507482A5 publication Critical patent/JP2014507482A5/ja
Application granted granted Critical
Publication of JP6204830B2 publication Critical patent/JP6204830B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013557912A 2011-03-11 2012-03-09 間葉系幹細胞エキソソームに関連する方法および組成物 Active JP6204830B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161451981P 2011-03-11 2011-03-11
US61/451,981 2011-03-11
PCT/US2012/028524 WO2012125471A1 (en) 2011-03-11 2012-03-09 Methods and compositions relating to mesenchymal stem cell exosomes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017168158A Division JP6524162B2 (ja) 2011-03-11 2017-09-01 間葉系幹細胞エキソソームに関連する方法および組成物

Publications (3)

Publication Number Publication Date
JP2014507482A JP2014507482A (ja) 2014-03-27
JP2014507482A5 true JP2014507482A5 (https=) 2016-09-01
JP6204830B2 JP6204830B2 (ja) 2017-09-27

Family

ID=45852770

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013557912A Active JP6204830B2 (ja) 2011-03-11 2012-03-09 間葉系幹細胞エキソソームに関連する方法および組成物
JP2017168158A Active JP6524162B2 (ja) 2011-03-11 2017-09-01 間葉系幹細胞エキソソームに関連する方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017168158A Active JP6524162B2 (ja) 2011-03-11 2017-09-01 間葉系幹細胞エキソソームに関連する方法および組成物

Country Status (8)

Country Link
US (3) US9901600B2 (https=)
EP (1) EP2683389B1 (https=)
JP (2) JP6204830B2 (https=)
KR (2) KR102063069B1 (https=)
CN (2) CN103648509B (https=)
CA (1) CA2829586C (https=)
ES (1) ES2629502T3 (https=)
WO (1) WO2012125471A1 (https=)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
CA2829586C (en) * 2011-03-11 2021-03-02 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
ITRM20110403A1 (it) * 2011-07-28 2013-01-29 Ospedale Pediatrico Bambino Gesu Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori.
US9427450B2 (en) 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
GB201202319D0 (en) 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
AU2013302799B2 (en) 2012-08-13 2018-03-01 Cedars-Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
CN103865873B (zh) * 2012-12-12 2017-04-05 中国医学科学院基础医学研究所 亚全能干细胞分泌的外来体及其应用
CN115919901A (zh) * 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法
CN105264092B (zh) * 2013-03-15 2019-02-22 得克萨斯州大学系统董事会 用于诊断和疗法的外来体中的miRNA生物发生
WO2014197421A1 (en) 2013-06-05 2014-12-11 Biotime, Inc. Compositions and methods for induced tissue regeneration in mammalian species
ES2909752T3 (es) * 2013-08-01 2022-05-10 Swedish Stromabio Ab MSC en el tratamiento de enfermedades pulmonares inflamatorias
GB201317887D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product
CN104694466A (zh) * 2013-12-06 2015-06-10 山西医科大学 间充质干细胞来源的胞外体制备及在急性肺损伤中的应用
KR101662405B1 (ko) * 2013-12-12 2016-10-05 사회복지법인 삼성생명공익재단 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌혈관 질환 치료용 약학적 조성물
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
US9919011B2 (en) 2014-03-18 2018-03-20 Samsung Life Public Welfare Foundation Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome
CA2949083C (en) 2014-05-18 2023-10-10 Children's Medical Center Corporation Methods and compositions relating to exosomes
WO2015191545A1 (en) * 2014-06-09 2015-12-17 University Of Washington Methods of protection against ischemia reperfusion injury
WO2016001846A1 (en) * 2014-06-30 2016-01-07 Tigenix S.A.U. Mesenchymal stromal cells for treating sepsis
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
EP3209768A1 (en) 2014-07-25 2017-08-30 Recellerate Inc. Methods of treating exercise-induced pulmonary hemorrhage
CA2962444C (en) 2014-10-03 2023-09-05 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
EP3204117A4 (en) * 2014-10-06 2018-05-09 Cedars-Sinai Medical Center Polarization of macrophages to a healing phenotype by cardiosphere-derived cells and by the exosomes secreted by such cells
WO2016072821A1 (ko) * 2014-11-07 2016-05-12 한양대학교 에리카산학협력단 줄기세포 유래 엑소좀을 함유하는 지방세포 분화유도, 지방조직 재생, 피부 미백 또는 주름개선용 조성물
JP6683700B2 (ja) * 2014-11-07 2020-04-22 株式会社エキソステムテックExostemtech Co.,Ltd. 幹細胞由来のエキソソームを含有する脂肪細胞分化誘導、または脂肪組織の再生用組成物の製造方法
JP6716564B2 (ja) * 2014-12-03 2020-07-01 カプリコール,インコーポレイテッド 安定したエクソソーム製剤の製造方法
CN104560877B (zh) * 2014-12-18 2017-07-28 福州市传染病医院 一种快速分离细胞外吐小体的方法
US20180264047A1 (en) * 2014-12-24 2018-09-20 Ube Industries, Ltd. Cell culture supernatant fluid derived from lung tissue
WO2016111899A1 (en) * 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
US20180325830A1 (en) 2017-05-09 2018-11-15 Vivex Biomedical, Inc. Coated biological composition
US11160904B2 (en) * 2017-05-09 2021-11-02 Vivex Biologies Group, Inc. Biological composition in a protectant shroud and methods
US9687511B2 (en) 2015-03-06 2017-06-27 Vivex Biomedical, Inc. Acellular biologic composition and method of manufacture
KR101566450B1 (ko) * 2015-04-03 2015-11-05 (유)스템메디케어 중간엽 줄기세포에서 단백질의 대량 생산 방법
US11160834B2 (en) 2015-04-28 2021-11-02 The Texas A&M University System Scalable production of standardized extracellular vesicles, extracellular vesicle preparations and uses thereof
US20180177727A1 (en) * 2015-06-10 2018-06-28 Board Of Regents, The University Of Texas System Use of exosomes for the treatment of disease
US11320441B2 (en) 2015-06-10 2022-05-03 Children's National Medical Center Adipocyte-derived exosomes, and compositions, kits, and methods of using the same for detection and screening
CN114984054B (zh) * 2015-06-12 2025-04-01 哈德逊医学研究中心 一种治疗方法
US11077147B2 (en) * 2015-07-20 2021-08-03 Vivex Biologics Group, Inc. Acellular biologic composition and method of manufacture
WO2017023690A1 (en) * 2015-07-31 2017-02-09 Exoceuticals, Inc. Exosome compositions and methods for preparation and use thereof for regulating and conditioning skin and hair
CA3202332A1 (en) 2015-12-07 2017-06-15 Agex Therapeutics, Inc. Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
EP3402543B1 (en) 2016-01-11 2021-09-08 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
EP3922253A1 (en) * 2016-01-15 2021-12-15 Orbsen Therapeutics Limited Sdc-2 exosome compositions and methods of isolation and use
EP3407844A4 (en) 2016-01-29 2019-10-16 Qool Therapeutics, Inc. AEROSOLISATION OF STEM CELLS OR STEM CELL DERIVATIVES FOR PULMONARY ADMINISTRATION
KR101843634B1 (ko) * 2016-04-15 2018-03-30 사회복지법인 삼성생명공익재단 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 만성폐질환 치료용 조성물
WO2017210652A1 (en) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Cdc-derived exosomes for treatment of ventricular tachyarrythmias
KR20250037589A (ko) * 2016-06-17 2025-03-17 유나이티드 쎄러퓨틱스 코포레이션 향상된 효능을 가진 세포외 소포
US10946047B2 (en) * 2016-06-17 2021-03-16 United Therapeutics Corporation Extracellular vesicles with enhanced potency
KR102503101B1 (ko) * 2016-08-03 2023-02-23 고쿠리츠 다이가쿠 호우징 도우카이 고쿠리츠 다이가쿠 기코우 다능성 간세포에 따른 만성폐질환의 개선 및 치료
CA3032925A1 (en) * 2016-08-03 2018-02-08 Life Science Institute, Inc. Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
EP3494977A4 (en) * 2016-08-05 2020-03-18 Exostemtech Co., Ltd. COMPOSITION FOR THE PREVENTION OR TREATMENT OF LUNG FIBROSE WITH FAT TISSUE EXOSOM OBTAINED FROM STEM CELLS AS AN ACTIVE SUBSTANCE
US11541078B2 (en) 2016-09-20 2023-01-03 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
WO2018071677A1 (en) * 2016-10-13 2018-04-19 Vbc Holdings Llc Medical uses of exosomes
CN110072991A (zh) * 2016-10-13 2019-07-30 Vbc控股有限责任公司 来源于发炎的细胞或组织的抗炎外泌体
JP7248984B2 (ja) * 2017-02-28 2023-03-30 ユニバーシティ デ ロライン 敗血症の治療のための、ワルトンジェリーから取得された間葉系幹細胞
US20180291336A1 (en) * 2017-04-07 2018-10-11 Robert John Petcavich Method of manufacturing and purifying exosomes from non-terminally differentiated cells
EP4699658A2 (en) 2017-04-19 2026-02-25 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
TWI704923B (zh) * 2017-06-26 2020-09-21 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 包含胞外囊泡之製劑、用以製備該製劑之方法及其用途
US12377120B2 (en) 2017-07-06 2025-08-05 Children's National Medical Center Exosomes and methods of use thereof
KR20190011213A (ko) * 2017-07-24 2019-02-01 한양대학교 에리카산학협력단 줄기세포로부터 추출된 엑소좀을 유효성분으로 포함하는 골다공증 예방 또는 치료용 조성물
CA3072562A1 (en) 2017-08-15 2019-02-21 Children's Medical Center Corporation Purified mesenchymal stem cell exosomes and uses thereof
US11471559B2 (en) * 2017-11-20 2022-10-18 Vivex Biologics Group, Inc. Bioenergetic bone
US11660355B2 (en) 2017-12-20 2023-05-30 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
US12146137B2 (en) 2018-02-05 2024-11-19 Cedars-Sinai Medical Center Methods for therapeutic use of exosomes and Y-RNAS
CN112334190B (zh) 2018-04-30 2024-09-20 儿童医学中心公司 间充质基质细胞外排体及其用途
US12031976B2 (en) 2018-05-04 2024-07-09 Samsung Life Public Welfare Foundation Screening method for therapeutic substance for preventing or treating bronchopulmonary dysplasia (BPD)
JP2021526556A (ja) * 2018-05-30 2021-10-07 ダイレクト バイオロジクス エルエルシー 成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞(msc)の調製物を含む助剤、ならびにその使用方法
KR102863376B1 (ko) * 2018-06-11 2025-09-24 헬스 앤드 바이오테크 프랑스 (에이치 앤드 비 프랑스) 중간엽 줄기 세포로부터 유래된 세포외 소포
EP3813858B1 (en) * 2018-06-29 2023-11-01 North Carolina State University Therapeutic lung repair by inhalation of lung spheroid exosomes
AU2019312212B2 (en) * 2018-07-24 2024-10-10 Mayo Foundation For Medical Education And Research Compositions and methods involving transforming extracellular vesicles
MA53273A (fr) 2018-08-10 2021-06-16 Omnispirant Ltd Vésicules extracellulaires pour inhalation
EP3879980A4 (en) * 2018-11-15 2022-08-24 Washington University EXTRACELLULAR VESICLES DERIVED FROM STEM CELLS AND METHODS OF USE THEREOF
BR112021015549A2 (pt) 2019-02-07 2021-10-26 Direct Biologics Llc Método para tratar osteoartrite com uma combinação de exossomos de células tronco mesenquimais, células tronco mesenquimais sinoviais e andaimes
AU2020228303B2 (en) * 2019-02-28 2025-09-18 Merakris Therapeutics Llc Amniotic fluid-derived extracellular vesicles and uses thereof for wound healing
JP7372518B2 (ja) * 2019-06-27 2023-11-01 国立大学法人山口大学 骨髄由来間葉系幹細胞の培養方法
CA3146433A1 (en) 2019-07-18 2021-01-21 Direct Biologics Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
CN114269358A (zh) * 2019-07-31 2022-04-01 上海圣特佳健康科技发展有限公司 针对纤维化、炎症、和/或老化疾病的治疗药物
US20210052641A1 (en) * 2019-08-23 2021-02-25 United Therapeutics Corporation Pre-conditioned extracellular vesicles and methods of production
CN110777113B (zh) * 2019-09-10 2021-09-24 中山大学 一种用于日本血吸虫感染治疗的间质干细胞处理方法
CA3163871A1 (en) * 2019-12-04 2021-06-10 United Therapeutics Corporation Extracellular vesicles and their uses
CN113384597A (zh) * 2020-03-13 2021-09-14 西比曼生物科技(上海)有限公司 含人体细胞衍生的细胞膜外囊泡的雾化吸入制剂、制法及其应用
CN111346110A (zh) * 2020-03-17 2020-06-30 遵义医学院附属医院 间充质干细胞上清液在制备治疗肺细胞损伤制剂中的应用
US12590310B2 (en) 2020-04-22 2026-03-31 Direct Biologics, Llc Methods and compositions for treating inflammatory conditions associated with infectious disease
EP4179072B1 (en) * 2020-07-09 2025-09-03 Exo Biologics Sa Process for the manufacturing of protein-associated extracellular vesicles
US20230248773A1 (en) 2020-07-09 2023-08-10 Exo Biologics Sa Extracellular Vesicles and Compositions Thereof
WO2022018729A1 (en) * 2020-07-20 2022-01-27 Brainstorm Cell Therapeutics Ltd. Methods and compositions for treating lung conditions
CN112043686A (zh) * 2020-09-21 2020-12-08 沈阳三禾生物科技有限公司 脐带间充质干细胞外泌体雾化液在制备治疗哮喘产品中的应用
CN112007049A (zh) * 2020-09-21 2020-12-01 济南磐升生物技术有限公司 一种用于治疗膝骨关节炎的干细胞外泌体组合物
EP4240323A1 (en) * 2020-11-06 2023-09-13 AATEC Medical GmbH A composition comprising extra-cellular vesicles from mesenchymal stem cells and alpha-1 antitrypsin for the treatment of viral infections
EP3995130A1 (en) * 2020-11-06 2022-05-11 JunctuCell Biomed Manufacturing GmbH A composition comprising extra-cellular vesicles from mesenchymal stem cells and alpha-1 antitrypsin for the treatment of viral infections
EP4252761A4 (en) * 2020-11-26 2024-06-05 Samsung Life Public Welfare Foundation COMPOSITION FOR THE TREATMENT OF INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-PROCESSED STEM CELLS
USD1046870S1 (en) 2020-12-08 2024-10-15 Samsung Electronics Co., Ltd. Accessory panel for television receiver
CN112675203A (zh) * 2021-02-08 2021-04-20 瑞太生物科技(沈阳)有限公司 一种细胞来源的外泌体在制备治疗哮喘和/或肺纤维化生物制剂中的应用
US20240376434A1 (en) 2021-09-16 2024-11-14 Life Technologies Corporation Cell expansion methods and compositions for use therein
JP7773257B2 (ja) 2022-03-28 2025-11-19 合同会社HiRoko Science miR-140を含む医薬組成物及びその製造方法
CN115725499B (zh) * 2022-08-15 2025-08-15 哈尔滨医科大学 一种人脐带间充质干细胞膜仿生纳米囊泡的制备方法和应用
CN116897887A (zh) * 2023-07-31 2023-10-20 湖南中医药大学 一种病毒性哮喘动物模型的构建方法
US12502407B2 (en) 2024-04-25 2025-12-23 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles
WO2025250774A1 (en) * 2024-05-31 2025-12-04 Leksum LLC Extracellular vesicles for therapy

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
FR2766205B1 (fr) * 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US20030221199A1 (en) * 1998-10-20 2003-11-27 Whitsett Jeffrey A. Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
US20040214783A1 (en) * 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
BRPI0617085A2 (pt) 2005-09-02 2016-11-08 Agency Science Tech & Res método para obter uma célula-tronco mesenquimal (msc), célula ou linhagem celular, método para derivar uma cultura celular a partir de uma célula-tronco embrionária, método para tratamento de uma doença, uso de uma célula-tronco mesenquimal, linhagem diferenciada, composição farmacêutica, método para condicionar um meio de cultura celular, meio condicionado e uso do mesmo, mpetodo para obterum polipeptídeo, método para obtar uma cultura celular, cultura celular, célula-tronco mesenquimal, linhagem de célula-tronco mesenquimal ou uma célula mesenquimal diferenciada
WO2007124594A1 (en) * 2006-04-27 2007-11-08 Cell Therapy Technologies, Inc. Et Al. Stem cells for treating lung diseases
EP2617428A1 (en) 2006-08-15 2013-07-24 Agency for Science, Technology and Research Mesenchymal stem cell conditioned medium
EP2076116A4 (en) * 2006-10-11 2010-04-07 Gen Hospital Corp COMPOSITIONS, METHODS, AND DEVICES FOR TREATING HEPATIC DISEASES
CN102014934B (zh) * 2008-02-22 2014-08-20 新加坡科技研究局 间充质干细胞颗粒
EP2456861A4 (en) 2009-07-23 2013-12-04 Agency Science Tech & Res PRENATAL MESENCHYMAL STEM CELLS
SG2014010698A (en) 2009-11-02 2014-05-29 Agency Science Tech & Res Methods of monitoring cellular states
KR101189655B1 (ko) * 2010-06-30 2012-10-11 성균관대학교산학협력단 줄기세포 배양액을 포함하는 폐질환 치료용 조성물
CN101890050B (zh) 2010-07-14 2012-07-04 江苏大学 脐带间质干细胞来源膜性囊泡及其应用
CA2845280A1 (en) 2010-08-13 2012-02-16 Paul Shiels Therapeutic uses of microvesicles and related micrornas
WO2012115885A1 (en) 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
CA2829586C (en) * 2011-03-11 2021-03-02 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
SG11201406336YA (en) 2012-04-03 2014-11-27 Reneuron Ltd Stem cell microparticles
CA2949083C (en) 2014-05-18 2023-10-10 Children's Medical Center Corporation Methods and compositions relating to exosomes

Similar Documents

Publication Publication Date Title
JP2014507482A5 (https=)
JP2015525757A5 (https=)
JP2012500090A5 (https=)
CL2012001836A1 (es) Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros.
IL215276A (en) Dry powdered compositions and their use in the preparation of drugs for the treatment of lung disease
MX2013004817A (es) Enfermedad inflamatoria.
LT4104824T (lt) Kompozicijos, skirtos panaudoti taikant pacientams su didele širdies ir kraujagyslių ligos rizika antsvorio ir nutukimo gydymo būdą
BR112014011981A8 (pt) Formulações farmacêuticas sólidas orais, seus processos de preparação e usos
JP2016014009A5 (https=)
JP2012512815A5 (https=)
JP2016538288A5 (https=)
PH12015502717A1 (en) Anti-fibrogenic compounds, methods and uses thereof
WO2014164280A8 (en) Micronized pharmaceutical compositions
JP2015536999A5 (https=)
TR200909788A2 (tr) Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
TR200907913A2 (tr) İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim
JP2013509443A5 (https=)
MY179215A (en) Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
TR200907915A2 (tr) Kuru toz formunda farmasötik bileşim.
TR201004317A2 (tr) Türbülans oluşumunu sağlayan inhalasyon cihazı.
Patterson et al. Effect Of Injured Lung Derived Inflammatory Mediators On Peripheral Organ Cells
WO2013109213A3 (en) Pharmaceutical formulations comprising tiotropium
CN302371352S (zh) 一次性使用人体酒精测试仪(2)
CN301973213S (zh) 椅子(gs-g1795b)
CN302243804S (zh) 游艺机(超级秋千)